Mexiletine hydrochloride

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Masahisa Katsuno

Conditions

HIV InfectionsPeripheral Nervous System DiseaseSpinal and Bulbar Muscular Atrophy

Phase 2

A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection

CompletedNCT00000793

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Peripheral Nervous System Disease

End: 1997-10-31Target: 240Updated: 2021-10-29

Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy

RecruitingNCT06862596

Masahisa KatsunoSpinal and Bulbar Muscular Atrophy

Start: 2025-02-28End: 2027-12-31Target: 68Updated: 2025-04-16